{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:12:39Z","timestamp":1773285159962,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"vor","delay-in-days":125,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Case Reports"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/j.ebcr.2016.04.005","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T07:02:56Z","timestamp":1463814176000},"page":"23-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Nonconvulsive status epilepticus cases arising in connection with cephalosporins"],"prefix":"10.1016","volume":"6","author":[{"given":"Ibrahim","family":"Bora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aylin Bican","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebcr.2016.04.005_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkh039","article-title":"Antimicrobial usage and resistance trend relationships from the MYSTIC programme in North America (1999\u20132001)","volume":"53","author":"Mutnick","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ebcr.2016.04.005_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(01)00767-7","article-title":"Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure","volume":"111","author":"Martinez-Rodriguez","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000077370","article-title":"Nonconvulsive status epilepticus during cephalosporin therapy","volume":"49","author":"Primavera","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0020","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0025","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.45.8.1499","article-title":"Complex partial status epilepticus accompanied by serious morbidity and mortality","volume":"45","author":"Krumholz","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0030","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.yebeh.2007.12.002","article-title":"Nonconvulsive status epilepticus","volume":"12","author":"Maganti","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10072-011-0668-3","article-title":"Cefixime-induced nonconvulsive status epilepticus","volume":"33","author":"Anzellotti","year":"2012","journal-title":"Neurol Sci"},{"issue":"11","key":"10.1016\/j.ebcr.2016.04.005_bb0040","first-page":"1981","article-title":"Cefazolin induced seizures in hemodialysis patients","volume":"89","author":"Arkaravichien","year":"2006","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"10.1016\/j.ebcr.2016.04.005_bb0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0050","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3346\/jkms.2012.27.9.1120","article-title":"Ceftriaxone-induced neurotoxicity: case report, pharmacokinetic consideration, and literature review","volume":"27","author":"Kim","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0055","first-page":"72","article-title":"Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection","volume":"67","author":"Roncan-Albuquerque","year":"2009","journal-title":"Neth J Med"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1592\/phco.26.8.1169","article-title":"Cefepime neurotoxicity: case report, pharmacokinetic considerations and literature review","volume":"26","author":"Lam","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2003.09.003","article-title":"Cefepime-induced encephalopathy","volume":"8","author":"Dakdouki","year":"2004","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebcr.2016.04.005_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.14581\/jer.13008","article-title":"Cefepime-induced nonconvulsive status epilepticus (NCSE)","volume":"3","author":"Kim","year":"2013","journal-title":"J Epilepsy Res"},{"issue":"3","key":"10.1016\/j.ebcr.2016.04.005_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0080","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/AAC.44.11.3217-3219.2000","article-title":"Effects of ceftazidime on systemic cytokine concentrations in rats","volume":"44","author":"Alkharfy","year":"2000","journal-title":"Anti-microb Agents Chemother"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00134-004-2285-6","article-title":"Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy","volume":"30","author":"Eggers","year":"2004","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ebcr.2016.04.005_bb0090","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1528-1167.2005.16305.x","article-title":"Cephalosporin-induced nonconvulsive status epilepticus: clinical and electroencephalographic features","volume":"46","author":"Fernandez-Torre","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebcr.2016.04.005_bb0095","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00023210-200115120-00003","article-title":"Diagnosis and treatment of non-convulsive status epilepticus","volume":"15","author":"Walker","year":"2001","journal-title":"CNS Drugs"}],"container-title":["Epilepsy & Behavior Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323216300196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213323216300196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:58:11Z","timestamp":1536706691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213323216300196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"alternative-id":["S2213323216300196"],"URL":"https:\/\/doi.org\/10.1016\/j.ebcr.2016.04.005","relation":{},"ISSN":["2213-3232"],"issn-type":[{"value":"2213-3232","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonconvulsive status epilepticus cases arising in connection with cephalosporins","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebcr.2016.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}